Market Cap 1.21B
Revenue (ttm) 568.09M
Net Income (ttm) 22.73M
EPS (ttm) N/A
PE Ratio 19.32
Forward PE 18.70
Profit Margin 4.00%
Debt to Equity Ratio 0.90
Volume 748,000
Avg Vol 751,100
Day's Range N/A - N/A
Shares Out 84.09M
Stochastic %K 62%
Beta 0.63
Analysts Strong Sell
Price Target $16.80

Company Profile

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted...

Industry: Medical Devices
Sector: Healthcare
Phone: 919 474 6700
Address:
4721 Emperor Boulevard, Suite 100, Durham, United States
1manfund
1manfund Aug. 21 at 11:38 AM
Aside from $MRK I am interested in $BVS and $TLX in the Pharma space Time to put the learned context to use
0 · Reply
farcanal
farcanal Aug. 5 at 10:02 PM
$BVS +1549% What a difference 3 years has made compared to relentless stagnaters like ZVRA and ARDX. The exit of Ken Reali as CEO in Apr 2023 marked the beginning of the turnaround and it sparked my entry point, and his replacement has proven to be a great investment. Time now to bank the profits and take a break! 👏
0 · Reply
RunnerSignals
RunnerSignals Aug. 5 at 8:36 PM
$FUBO reversed from -9.5% at the open to +11.6% on 2.6x volume, while $BVS flipped -5.4% to +13.7% on 3.4x volume. the close reads as short covering reinforced by accumulation, favoring follow-through over exhaustion
0 · Reply
stockpicker63
stockpicker63 Aug. 5 at 5:49 PM
Stocks to watch today! $ELF, $ZETA, $BVS and $SHOP
0 · Reply
PeaceLoveAndHarmony
PeaceLoveAndHarmony Aug. 5 at 1:59 PM
$BVS How on earth was this 11.11 in premarket 😂
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 1:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-bioventus-inc-stock-1/ $BVS Bioventus Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 11:47 AM
$BVS Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.49 up 345.45% YoY • Reported revenue of $153.21M up 3.76% YoY
0 · Reply
Retireby40__
Retireby40__ Aug. 3 at 2:12 PM
$BVS we have lift off 🚀
0 · Reply
LewisDaKat
LewisDaKat Jul. 29 at 4:00 PM
$BVS Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026 https://marketwirenews.com/stock/bvs/news/bioventus-to-report-second-quarter-of-fiscal-year-20-6606961343535595.html?utm_source=stocktwits
0 · Reply
_Yqav
_Yqav Jul. 28 at 8:08 PM
$BVS the breakout is officially in. there will probably be a retest tommorow but afterwards I dont see anything stopping it. 16.75 before 2027
0 · Reply
Latest News on BVS
Bioventus price target raised to $19 from $15 at Canaccord

2026-08-17T11:10:56.000Z - 4 days ago

Bioventus price target raised to $19 from $15 at Canaccord


Bioventus price target raised to $18 from $16 at Craig-Hallum

2026-08-06T13:25:29.000Z - 15 days ago

Bioventus price target raised to $18 from $16 at Craig-Hallum


Bioventus price target raised to $18 from $14 at Barrington

2026-08-06T12:02:34.000Z - 15 days ago

Bioventus price target raised to $18 from $14 at Barrington


Bioventus reports Q2 EPS 22c, consensus 22c

2026-08-05T14:24:23.000Z - 16 days ago

Bioventus reports Q2 EPS 22c, consensus 22c


Bioventus backs FY26 adjusted EPS view 75c-79c, consensus 78c

2026-08-05T14:23:50.000Z - 16 days ago

Bioventus backs FY26 adjusted EPS view 75c-79c, consensus 78c


Bioventus initiates review of strategic alternatives

2026-08-05T14:23:07.000Z - 16 days ago

Bioventus initiates review of strategic alternatives


Bioventus Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 16 days ago

Bioventus Earnings Call Transcript: Q2 2026


Bioventus Earnings release: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 16 days ago

Bioventus Earnings release: Q2 2026


Bioventus Quarterly report: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 16 days ago

Bioventus Quarterly report: Q2 2026


Bioventus Slides: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 16 days ago

Bioventus Slides: Q2 2026


Bioventus Reports Second Quarter Financial Results

Aug 5, 2026, 7:30 AM EDT - 16 days ago

Bioventus Reports Second Quarter Financial Results


Bioventus management to meet with Barrington

2026-06-16T20:08:51.000Z - 2 months ago

Bioventus management to meet with Barrington


Bioventus Transcript: AGM 2026

Jun 3, 2026, 10:00 AM EDT - 2 months ago

Bioventus Transcript: AGM 2026


Bioventus reports Q1 EPS 15c, consensus 7c

2026-05-07T06:30:12.000Z - 3 months ago

Bioventus reports Q1 EPS 15c, consensus 7c


Bioventus raises FY26 adjusted EPS view to 75c-79c from 73c-77c

2026-05-07T06:26:59.000Z - 3 months ago

Bioventus raises FY26 adjusted EPS view to 75c-79c from 73c-77c


Bioventus Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Bioventus Earnings Call Transcript: Q1 2026


Bioventus Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Bioventus Earnings release: Q1 2026


Bioventus Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Bioventus Quarterly report: Q1 2026


Bioventus Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Bioventus Slides: Q1 2026


Bioventus Reports First Quarter Financial Results

May 6, 2026, 7:30 AM EDT - 3 months ago

Bioventus Reports First Quarter Financial Results


Bioventus Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Bioventus Proxy statement: Proxy filing


Bioventus Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

Bioventus Proxy statement: Proxy filing


Bioventus initiated with an Outperform at CJS Securities

2026-03-27T13:00:51.000Z - 5 months ago

Bioventus initiated with an Outperform at CJS Securities


Bioventus Slides: Corporate presentation

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Bioventus Slides: Corporate presentation


Bioventus management to meet with Barrington

2026-03-09T18:55:09.000Z - 5 months ago

Bioventus management to meet with Barrington


Bioventus price target raised to $16 from $15 at Craig-Hallum

2026-03-06T14:05:43.000Z - 6 months ago

Bioventus price target raised to $16 from $15 at Craig-Hallum


Bioventus price target raised to $14 from $13 at Barrington

2026-03-06T12:35:37.000Z - 6 months ago

Bioventus price target raised to $14 from $13 at Barrington


Bioventus Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Bioventus Earnings Call Transcript: Q4 2025


Bioventus Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Bioventus Annual report: Q4 2025


Bioventus Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Bioventus Earnings release: Q4 2025


Bioventus Slides: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Bioventus Slides: Q4 2025


Bioventus sees FY26 adjusted EPS 73c-77c, consensus 77c

2026-03-05T12:21:28.000Z - 6 months ago

Bioventus sees FY26 adjusted EPS 73c-77c, consensus 77c


Bioventus reports Q4 EPS 24c, consensus 22c

2026-03-05T12:13:21.000Z - 6 months ago

Bioventus reports Q4 EPS 24c, consensus 22c


Bioventus initiated with an Outperform at Barrington

2026-02-09T13:00:47.000Z - 6 months ago

Bioventus initiated with an Outperform at Barrington


Bioventus Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 12:45 PM EST - 7 months ago

Bioventus Slides: 44th Annual J.P. Morgan Healthcare Conference


Bioventus Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Bioventus Earnings Call Transcript: Q3 2025


Bioventus Quarterly report: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Bioventus Quarterly report: Q3 2025


Bioventus Earnings release: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Bioventus Earnings release: Q3 2025


Bioventus Slides: Q3 2025

Nov 4, 2025, 8:30 AM EST - 10 months ago

Bioventus Slides: Q3 2025


Bioventus reports Q3 EPS 15c vs 5c last year

2025-11-04T12:41:02.000Z - 10 months ago

Bioventus reports Q3 EPS 15c vs 5c last year


Bioventus sees FY25 EPS 64c-68c

2025-11-04T12:40:38.000Z - 10 months ago

Bioventus sees FY25 EPS 64c-68c


Bioventus Reports Third Quarter Financial Results

Nov 4, 2025, 7:30 AM EST - 10 months ago

Bioventus Reports Third Quarter Financial Results


Bioventus Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings Call Transcript: Q2 2025


Bioventus Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Quarterly report: Q2 2025


Bioventus Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings release: Q2 2025


Bioventus Slides: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Slides: Q2 2025


Bioventus reports Q2 EPS 21c, consensus 20c

2025-08-06T11:15:44.000Z - 1 year ago

Bioventus reports Q2 EPS 21c, consensus 20c


Bioventus Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings Call Transcript: Q1 2025


Bioventus Quarterly report: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Quarterly report: Q1 2025


Bioventus Earnings release: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings release: Q1 2025


Bioventus Slides: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Bioventus Slides: Q1 2025


Bioventus Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Bioventus Proxy statement: Proxy Filing


Bioventus Proxy statement: Proxy Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Bioventus Proxy statement: Proxy Filing


Bioventus Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings Call Transcript: Q4 2024


Bioventus Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Bioventus Annual report: Q4 2024


Bioventus Earnings release: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Bioventus Earnings release: Q4 2024


Bioventus Slides: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Bioventus Slides: Q4 2024


Bioventus Slides: FY 2025

Jan 15, 2025, 1:30 PM EST - 1 year ago

Bioventus Slides: FY 2025


Bioventus Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Bioventus Earnings Call Transcript: Q3 2024


Bioventus Quarterly report: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Bioventus Quarterly report: Q3 2024


Bioventus Earnings release: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Bioventus Earnings release: Q3 2024


Bioventus Slides: Q3 2024

Nov 5, 2024, 8:30 AM EST - 1 year ago

Bioventus Slides: Q3 2024


Bioventus Registration statement: Registration Filing

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Bioventus Registration statement: Registration Filing


Bioventus Slides: FY 2024

Aug 14, 2024, 9:00 AM EDT - 2 years ago

Bioventus Slides: FY 2024


Bioventus Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings Call Transcript: Q2 2024


Bioventus Quarterly report: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

Bioventus Quarterly report: Q2 2024


Bioventus Earnings release: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings release: Q2 2024


Bioventus Slides: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

Bioventus Slides: Q2 2024


Bioventus Proxy statement: Proxy Filing

Jun 3, 2024, 8:00 AM EDT - 2 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings Call Transcript: Q1 2024


Bioventus Quarterly report: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Bioventus Quarterly report: Q1 2024


Bioventus Earnings release: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings release: Q1 2024


Bioventus Slides: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

Bioventus Slides: Q1 2024


Bioventus Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Earnings Call Transcript: Q4 2023

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings Call Transcript: Q4 2023


Bioventus Annual report: Q4 2023

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Bioventus Annual report: Q4 2023


Bioventus Earnings release: Q4 2023

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Bioventus Earnings release: Q4 2023


Bioventus Slides: Q4 2023

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Bioventus Slides: Q4 2023


Bioventus Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:30 AM EST - 3 years ago

Bioventus Earnings Call Transcript: Q3 2023


Bioventus Quarterly report: Q3 2023

Nov 7, 2023, 8:30 AM EST - 3 years ago

Bioventus Quarterly report: Q3 2023


Bioventus Earnings release: Q3 2023

Nov 7, 2023, 8:30 AM EST - 3 years ago

Bioventus Earnings release: Q3 2023


Bioventus Slides: Q3 2023

Nov 7, 2023, 8:30 AM EST - 3 years ago

Bioventus Slides: Q3 2023


Bioventus to Present at the Cantor Global Healthcare Conference

Sep 19, 2023, 9:52 PM EDT - 3 years ago

Bioventus to Present at the Cantor Global Healthcare Conference


Bioventus Earnings Call Transcript: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Bioventus Earnings Call Transcript: Q2 2023


Bioventus Quarterly report: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Bioventus Quarterly report: Q2 2023


Bioventus Earnings release: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Bioventus Earnings release: Q2 2023


Bioventus Slides: Q2 2023

Aug 8, 2023, 8:30 AM EDT - 3 years ago

Bioventus Slides: Q2 2023


Bioventus Completes Divestiture of its Wound Business

May 23, 2023, 7:30 AM EDT - 3 years ago

Bioventus Completes Divestiture of its Wound Business


Bioventus Earnings Call Transcript: Q1 2023

May 16, 2023, 5:00 PM EDT - 3 years ago

Bioventus Earnings Call Transcript: Q1 2023


Bioventus Quarterly report: Q1 2023

May 16, 2023, 5:00 PM EDT - 3 years ago

Bioventus Quarterly report: Q1 2023


Bioventus Earnings release: Q1 2023

May 16, 2023, 5:00 PM EDT - 3 years ago

Bioventus Earnings release: Q1 2023


Bioventus Slides: Q1 2023

May 16, 2023, 5:00 PM EDT - 3 years ago

Bioventus Slides: Q1 2023


Bioventus Announces Divestiture of its Wound Business

May 10, 2023, 9:00 AM EDT - 3 years ago

Bioventus Announces Divestiture of its Wound Business


Bioventus Proxy statement: Proxy Filing

Apr 27, 2023, 8:00 AM EDT - 3 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Proxy statement: Proxy Filing

Apr 27, 2023, 8:00 AM EDT - 3 years ago

Bioventus Proxy statement: Proxy Filing


Bioventus Announces CEO Leadership Change

Apr 5, 2023, 8:00 AM EDT - 3 years ago

Bioventus Announces CEO Leadership Change


Bioventus Earnings Call Transcript: Q4 2022

Mar 31, 2023, 8:30 AM EDT - 3 years ago

Bioventus Earnings Call Transcript: Q4 2022


Bioventus Annual report: Q4 2022

Mar 31, 2023, 8:30 AM EDT - 3 years ago

Bioventus Annual report: Q4 2022


Bioventus Earnings release: Q4 2022

Mar 31, 2023, 8:30 AM EDT - 3 years ago

Bioventus Earnings release: Q4 2022


Bioventus Slides: Q4 2022

Mar 31, 2023, 8:30 AM EDT - 3 years ago

Bioventus Slides: Q4 2022


1manfund
1manfund Aug. 21 at 11:38 AM
Aside from $MRK I am interested in $BVS and $TLX in the Pharma space Time to put the learned context to use
0 · Reply
farcanal
farcanal Aug. 5 at 10:02 PM
$BVS +1549% What a difference 3 years has made compared to relentless stagnaters like ZVRA and ARDX. The exit of Ken Reali as CEO in Apr 2023 marked the beginning of the turnaround and it sparked my entry point, and his replacement has proven to be a great investment. Time now to bank the profits and take a break! 👏
0 · Reply
RunnerSignals
RunnerSignals Aug. 5 at 8:36 PM
$FUBO reversed from -9.5% at the open to +11.6% on 2.6x volume, while $BVS flipped -5.4% to +13.7% on 3.4x volume. the close reads as short covering reinforced by accumulation, favoring follow-through over exhaustion
0 · Reply
stockpicker63
stockpicker63 Aug. 5 at 5:49 PM
Stocks to watch today! $ELF, $ZETA, $BVS and $SHOP
0 · Reply
PeaceLoveAndHarmony
PeaceLoveAndHarmony Aug. 5 at 1:59 PM
$BVS How on earth was this 11.11 in premarket 😂
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 1:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-bioventus-inc-stock-1/ $BVS Bioventus Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 11:47 AM
$BVS Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.49 up 345.45% YoY • Reported revenue of $153.21M up 3.76% YoY
0 · Reply
Retireby40__
Retireby40__ Aug. 3 at 2:12 PM
$BVS we have lift off 🚀
0 · Reply
LewisDaKat
LewisDaKat Jul. 29 at 4:00 PM
$BVS Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026 https://marketwirenews.com/stock/bvs/news/bioventus-to-report-second-quarter-of-fiscal-year-20-6606961343535595.html?utm_source=stocktwits
0 · Reply
_Yqav
_Yqav Jul. 28 at 8:08 PM
$BVS the breakout is officially in. there will probably be a retest tommorow but afterwards I dont see anything stopping it. 16.75 before 2027
0 · Reply
TheMarketAnalyst1
TheMarketAnalyst1 Jul. 16 at 8:59 PM
$BVS is missing one important piece 👀 The price action has been impressive, with what looks like a clean breakout followed by a successful retest. The only thing I’m watching closely is the volume on the continuation move. After the lower-volume retest, we still haven’t seen a meaningful increase in buying activity. Volume doesn’t always need to explode immediately, but for me, the best setups usually come with confirmation from both price and participation. Once volume starts picking up, this one becomes much more interesting. I’m not chasing every move, only looking for A+ setups with the right conditions. Time to review the session. Calling it a good trading day? Until tomorrow.
0 · Reply
ETAlpha
ETAlpha Jul. 16 at 7:12 PM
Perfect Setup, Missing Volume! $BVS executes textbook breakout-retest Bioventus ($BVS) is trading slightly higher around $12.30, consolidating nicely near its recent breakout highs. The price action has completed a flawless breakout and a standard lower-volume retest. However, we are still missing the crucial piece: a strong surge in buying volume on the continuation attempt. While a volume spike isn't required immediately, I only execute high-conviction A setups. Waiting for that volume confirmation before pulling the trigger. The complete $BVS breakout volume profiles, institutional accumulation metrics, and key momentum triggers are live on my profile.
0 · Reply
MarketIntel_
MarketIntel_ Jul. 16 at 6:56 PM
$BVS The setup is almost there, but one key piece is still missing. Price action has been textbook so far: a clean breakout followed by a successful retest. The only thing I want to see is stronger volume confirmation on the next move. The retest came in on lower volume, but buyers haven’t stepped in with a meaningful volume expansion yet. A volume surge would make this setup much more interesting. It’s not that price cannot move higher without it, but I’m focused on trading only the highest-quality A+ setups. Watching patiently for confirmation.
0 · Reply
JodieChristy
JodieChristy Jul. 13 at 12:54 PM
MA flips are the cleanest setups in this market. We are sitting on major inflection points right now: $CDE / $ASAN / EVO: All flipping the 200DMA into solid support. $RXRX: 50WMA holding like a brick wall. $BVS: Looking prime here. $LEGN: Textbook retest of the 200DMA. Every single chart with precise entry and exit targets has been uploaded to my profile.
0 · Reply
Valuebuilder
Valuebuilder Jul. 13 at 9:58 AM
$BVS take a look at what Avanos got bought at.Bioventus generates more profit and is a far better company.There is big value here!
0 · Reply
Yqav
Yqav Jul. 8 at 3:55 PM
$BVS holy cap and handle breaakout on the weekly chart. This stock has much more in it
0 · Reply
GordonGordon
GordonGordon Jul. 8 at 3:52 PM
$BVS I keep thinking about the 15,000 calls people bought the other day....
0 · Reply
GordonGordon
GordonGordon Jul. 8 at 3:52 PM
$BVS This is acting really well on a terrible day for the market!
0 · Reply
Spicy_Trade
Spicy_Trade Jul. 7 at 12:59 AM
Bioventus Inc. ( $BVS ) SpicyTrade - Daily Stock Analysis https://youtu.be/ihhMPbQwROg?si=XTWgIGPqX130VrxK
0 · Reply
TrendStalker_
TrendStalker_ Jul. 6 at 10:36 PM
$BVS showing strong breakout momentum, up another 12% today and poking just above key trendline resistance. Structurally, looking for a clean technical retest of this level to confirm the move. The macro wedge structure maps out a potential +69% gain to the top of the range.
0 · Reply
GordonGordon
GordonGordon Jul. 6 at 7:32 PM
$BVS 14,500 of the $12.50 calls have traded. Wow.
0 · Reply
kshonstocks
kshonstocks Jul. 6 at 3:10 PM
$BVS Bioventus shares rise after Medicare reverses reimbursement cuts
0 · Reply